Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Van Gelder IC, et al. Among authors: bosker ha. N Engl J Med. 2002 Dec 5;347(23):1834-40. doi: 10.1056/NEJMoa021375. N Engl J Med. 2002. PMID: 12466507 Free article. Clinical Trial.
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC; RACE Study Group. Hagens VE, et al. Among authors: bosker ha. J Am Coll Cardiol. 2004 Jan 21;43(2):241-7. doi: 10.1016/j.jacc.2003.08.037. J Am Coll Cardiol. 2004. PMID: 14736444 Free article.
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.
Hagens VE, Vermeulen KM, TenVergert EM, Van Veldhuisen DJ, Bosker HA, Kamp O, Kingma JH, Tijssen JG, Crijns HJ, Van Gelder IC; RACE study group. Hagens VE, et al. Among authors: bosker ha. Eur Heart J. 2004 Sep;25(17):1542-9. doi: 10.1016/j.ehj.2004.06.020. Eur Heart J. 2004. PMID: 15342174 Clinical Trial.
Clinical characteristics of persistent lone atrial fibrillation in the RACE study.
Rienstra M, Hagens VE, Van Veldhuisen DJ, Bosker HA, Tijssen JG, Kamp O, Bouma J, Veeger NJ, Crijns HJ, Van Gelder IC; RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Rienstra M, et al. Among authors: bosker ha. Am J Cardiol. 2004 Dec 15;94(12):1486-90. doi: 10.1016/j.amjcard.2004.08.024. Am J Cardiol. 2004. PMID: 15589001 Clinical Trial.
Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study.
Hagens VE, Van Veldhuisen DJ, Kamp O, Rienstra M, Bosker HA, Veeger NJ, Tijssen JG, Crijns HJ, Van Gelder IC; RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Hagens VE, et al. Among authors: bosker ha. Heart Rhythm. 2005 Jan;2(1):19-24. doi: 10.1016/j.hrthm.2004.09.028. Heart Rhythm. 2005. PMID: 15851259 Clinical Trial.
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study.
Hagens VE, Crijns HJ, Van Veldhuisen DJ, Van Den Berg MP, Rienstra M, Ranchor AV, Bosker HA, Kamp O, Tijssen JG, Veeger NJ, Van Gelder IC; RAte Control versus Electrical cardioversion for persistent atrial fibrillation study group. Hagens VE, et al. Among authors: bosker ha. Am Heart J. 2005 Jun;149(6):1106-11. doi: 10.1016/j.ahj.2004.11.030. Am Heart J. 2005. PMID: 15976795 Clinical Trial.
RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
Van Gelder IC, Van Veldhuisen DJ, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Bosker HA, Cornel JH, Kamp O, Veeger NJ, Volbeda M, Rienstra M, Ranchor AV, TenVergert EM, Van den Berg MP. Van Gelder IC, et al. Among authors: bosker ha. Am Heart J. 2006 Sep;152(3):420-6. doi: 10.1016/j.ahj.2006.02.033. Am Heart J. 2006. PMID: 16923407 Free article.
Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC. Hemels ME, et al. Among authors: bosker ha. J Am Coll Cardiol. 2006 Sep 5;48(5):1001-9. doi: 10.1016/j.jacc.2006.05.043. Epub 2006 Aug 17. J Am Coll Cardiol. 2006. PMID: 16949494 Free article. Clinical Trial.
Lenient versus strict rate control in patients with atrial fibrillation.
Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP; RACE II Investigators. Van Gelder IC, et al. Among authors: bosker ha. N Engl J Med. 2010 Apr 15;362(15):1363-73. doi: 10.1056/NEJMoa1001337. Epub 2010 Mar 15. N Engl J Med. 2010. PMID: 20231232 Free article. Clinical Trial.
63 results